These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3348469)

  • 1. Drug side effects and the double-blind design.
    Robinson ML
    Am J Psychiatry; 1988 Apr; 145(4):539. PubMed ID: 3348469
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers.
    McEvoy JP; McCue M; Spring B; Mohs RC; Lavori PW; Farr RM
    Am J Psychiatry; 1987 May; 144(5):573-7. PubMed ID: 3578566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
    Parkes JD; Baxter RC; Marsden CD; Rees JE
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of amantadine vs. trihexyphenidyl on memory in elderly normal volunteers.
    McEvoy JP; McCue M; Spring B; Mohs RC; Lavori PW; Farr R
    Psychopharmacol Bull; 1987; 23(1):30-2. PubMed ID: 3602327
    [No Abstract]   [Full Text] [Related]  

  • 5. The double-blind in danger: untoward consequences of informed consent.
    Brownell KD; Stunkard AJ
    Am J Psychiatry; 1982 Nov; 139(11):1487-9. PubMed ID: 6753613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased mental slowing associated with the APOE epsilon4 allele after trihexyphenidyl oral anticholinergic challenge in healthy elderly.
    Pomara N; Belzer K; Hernando R; De La Pena C; Sidtis JJ
    Am J Geriatr Psychiatry; 2008 Feb; 16(2):116-24. PubMed ID: 18239197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function.
    McEvoy JP
    J Clin Psychiatry; 1987 Sep; 48 Suppl():20-3. PubMed ID: 2887553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased anticholinergic challenge-induced memory impairment associated with the APOE-epsilon4 allele in the elderly: a controlled pilot study.
    Pomara N; Willoughby LM; Wesnes K; Sidtis JJ
    Neuropsychopharmacology; 2004 Feb; 29(2):403-9. PubMed ID: 14735126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-induced mental confusion during chemotherapy of psychiatric diseases. Possible role of trihexyphenidyl].
    Brion S; Guerin R
    Therapie; 1975; 30(3):447-50. PubMed ID: 1224365
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mental confusion during the treatment of Parkinson disease with trihexyphenidyl].
    Graux P; Durocher AM; Copin JM
    Lille Med; 1980; 25(6):271-2. PubMed ID: 7401896
    [No Abstract]   [Full Text] [Related]  

  • 11. Loss of teeth with antidepressant drug therapy.
    Winer JA; Bahn S
    Arch Gen Psychiatry; 1967 Feb; 16(2):239-40. PubMed ID: 6019340
    [No Abstract]   [Full Text] [Related]  

  • 12. [How blind is a double-blind trial really? Validity of controlled investigations].
    Modestin J; Hodel J
    Int Pharmacopsychiatry; 1977; 12(3):129-36. PubMed ID: 334685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More on the fallibility of the double-blind.
    Barsa JA
    Am J Psychiatry; 1983 Jun; 140(6):820-1. PubMed ID: 6846655
    [No Abstract]   [Full Text] [Related]  

  • 14. Memory and cognitive impairments in a case of long-term trihexyphenidyl abuse.
    Kajimura N; Mizuki Y; Kai S; Suetsugi M; Yamada M; Okuma T
    Pharmacopsychiatry; 1993 Mar; 26(2):59-62. PubMed ID: 8378414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuromuscular disorders due to adverse effects of antiparkinson agents].
    Hattori N
    Nihon Naika Gakkai Zasshi; 2007 Aug; 96(8):1614-20. PubMed ID: 17802710
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blinding in clinical trials.
    Ney PG
    CMAJ; 1989 Jan; 140(1):15. PubMed ID: 2909265
    [No Abstract]   [Full Text] [Related]  

  • 17. Amantadine versus trihexyphenidyl in the treatment of neuroleptic-induced parkinsonism.
    Fann WE; Lake CR
    Am J Psychiatry; 1976 Aug; 133(8):940-3. PubMed ID: 782262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms.
    Fayen M; Goldman MB; Moulthrop MA; Luchins DJ
    Am J Psychiatry; 1988 Apr; 145(4):483-6. PubMed ID: 2894780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind assessment of therapeutic efficacy in clinical trials.
    Cohen S
    Dig Dis Sci; 1983 Jun; 28(6):564-5. PubMed ID: 6861586
    [No Abstract]   [Full Text] [Related]  

  • 20. A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis.
    Bryson YJ; Monahan C; Pollack M; Shields WD
    J Infect Dis; 1980 May; 141(5):543-7. PubMed ID: 7373087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.